In terms of CRC, PIGU was identified as a key modulator that is closely related to KRAS mutant CRC patients (Zhang M. et al., 2020), while FBXW4 was reported to be associated with chemotherapy resistance and prognosis of CRC (Zhang Y. et al., 2020). This evidence concerns the gene KRAS and colorectal carcinoma.